Endosense
Medical company focused on improving the efficacy, safety and reproducibility of catheter ablation for the treatment of cardiac arrhythmias.
Launch date
Employees
Market cap
-
Enterprise valuation
€155m (Public information from Mar 2017)
Company register number CHE-110.065.846
Geneva Canton of Geneva (HQ)
Authorizing premium user...